Радионуклидная диагностика нестабильных атеросклеротических бляшек

Автор: Павлова Диана Александровна, Ефимова Наталия Юрьевна, Рыжкова Дарья Викторовна

Журнал: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk

Статья в выпуске: 1 т.29, 2014 года.

Бесплатный доступ

В работе обобщены литературные данные о радионуклидной диагностике атеросклеротического поражения сосудов. Особое внимание уделено характеристике гамма- и позитрон-излучающих радиофармацевтических препаратов, которые используют для молекулярной визуализации нестабильных бляшек.

Атеросклероз, нестабильная бляшка, радионуклидная диагностика, позитронная эмиссионная томография

Короткий адрес: https://sciup.org/14919908

IDR: 14919908

Список литературы Радионуклидная диагностика нестабильных атеросклеротических бляшек

Врублевский А.В., Бошенко А.В., Ицкович И.Э. и соавт. Современные методы визуализации коронарных артерий в диагностике коронарного атеросклероза//Кардиология. -2007. -Т. 47, № 7. -С. 83-93.
Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза//Рекомендации ВНОК. -М.: 2005. -С. 9-14.
Оганов Р.Г. Концепция факторов риска как основа профилактики сердечно-сосудистых заболеваний//Врач. -2001. -№ 7. -С. 3-6.
Alexopoulos N., Raggi P. Calcification in atherosclerosis//Nat. Rev. Cardiol. -2009. -Vol. 6. -P. 681-688.
Annovazzi A., Bonanno E., Arca M. et al. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques//Eur. J. Nucl. Med. Mol. Imaging. -2006. -Vol. 33. -P. 117-126.
Antonov A.S., Kolodgie F.D., Munn D.H. et al. Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis//Am. J. Pathol. -2004. -Vol. 165. -P. 247-258.
Ayala-Lopez W., Xia W., Varghese B. et al. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages//J. Nucl. Med. -2010. -Vol. 51. -P. 768-774.
Ben-Haim S., Kupzov E., Tamir A. et al. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT//J. Nucl. Med. -2004. -Vol. 45. -P. 1816-1821.
Bozoky Z., Balogh L., Mathe D. et al. Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia//Eur. Biophys. J. -2004. -Vol. 33. -P. 140-145.
Canat X., Guillaumont A., Bouaboula M. et al. Peripheral benzodiazepine receptor modulation with phagocyte differentiation//Biochem. Pharmacol. -1993. -Vol. 46. -P. 551-554.
Chiu J.J., Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives//Physiol. Rev. -2011. -Vol. 91. -P. 327-387.
Dalm V.A., van Hagen P.M., van Koetsveld P.M. et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells//Am. J. Physiol. Endocrinol. Metab. -2003. -Vol. 285. -E344-E353.
Davies J.R., Rudd J.H., Fryer T.D. et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and highresolution magnetic resonance imaging//Stroke. -2005. -Vol. 36. -P. 2642-2647.
Davies M.J., Richardson P.D., Woolf N. et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content//Br. Heart J. -1993. -Vol. 69. -P. 377-381.
Falk E., Shah P.K., Fuster V. Coronary plaque disruption//Circulation. -1995. -Vol. 92. -P. 657-671.
Falk E. Pathogenesis of atherosclerosis//J. Am. Coll. Cardiol. -2006. -Vol. 47. -P. 7-12.
Fayad Z.A., Mani V., Woodward M. et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial//Lancet. -2011. -Vol. 378. -P. 1547-1559.
Frayn K. The glucose-fatty acid cycle: a physiological perspective//Biochem. Soc. Trans. -2003. -Vol. 31. -P. 1115-1119.
Fujimoto S., Hartung D., Ohshima S. et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy//J. Am. Coll. Cardiol. -2008. -Vol. 52. -P. 1847-1857.
Gaemperli O., Shalhoub J., Owen D.R. et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography//Eur. Heart. J. -2012. -Vol. 33. -P. 1902-1910.
George R.T. 18F-sodium fluoride positron emission tomography: an in vivo window into coronary atherosclerotic plaque biology//J. Am. Coll. Cardiol. -2012. -Vol. 59. -P. 1549-1550.
Greenland P., LaBree L., Azen S.P. et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals//JAMA. -2004. -Vol. 291. -P. 210215.
Haider. N., Hartung. D., Fujimoto. S. et al. Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis//J. Nucl. Cardiol. -2009. -Vol. 16. -P. 753-762.
Hartung D., Petrov A., Haider N. et al. Radiolabeled Monocyte Chemotactic Protein 1 for the detection of inflammation in experimental atherosclerosis//J. Nucl. Med. -2007. -Vol. 48. -P. 1816-1821.
Hartung D., Sarai M., Petrov A. et al. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy//J. Nucl. Med. -2005. -Vol. 46. -P. 2051-2056.
Hoshiga M., Alpers C.E., Smith L.L. et al. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery//Circ Res. -1995. -Vol. 77. -P. 1129-1135.
Ishino S., Kuge Y., Takai N. et al. 99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits//Eur. J. Nucl. Med. Mol. Imaging. -2007. -Vol. 34. -P. 889-890.
Isobe S., Tsimikas S., Zhou J. et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5//J. Nucl. Med. -2006. -Vol. 47. -P. 1497-1505.
Iuliano L., Signore A., Vallabajosula S. et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man//Atherosclerosis. -1996. -Vol. 126. -P. 131-141.
Johnson L.L., Schofield L., Donahay T. et al. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries//J. Nucl. Med. -2005. -Vol. 46. -P. 1186-1193.
Kato K., Schober O., Ikeda M. et al. Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT//Eur. J. Nucl. Med. Mol. Imaging. -2009. -Vol. 36. -P. 1622-1628.
Kietselaer B.L., Reutelingsperger C.P., Heidendal G.A. et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis//N. Engl. J. Med. -2004. -Vol. 350. -P. 14721473.
Kolodgie F.D., Petrov A., Virmani R. et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque//Circulation. -2003. -Vol. 108. -P. 3134-3139.
Koopman G., Reutelingsperger C.P., Kuijten G.A. et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis//Blood. -1994. -Vol. 84. -P. 1415-1420.
Kuge Y., Takai N., Ogawa Y. et al. Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques//Eur. J. Nucl. Med. Mol. Imaging. -2010. -Vol. 37. -P. 20932104.
Kwee R.M., Truijman M.T., Mess W.H. et al. Potential of integrated fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques//AJNR Am. J. Neuroradiol. -2011. -Vol. 32. -P. 950-954.
Kzhyshkowska J., Neyen C., Gordon S. Role of macrophage scavenger receptors in atherosclerosis//Immunobiology. -2012. -Vol. 217. -P. 492-502.
Laitinen I., Marjamaki P., Haaparanta M. et al. Uptake of PK11195, a marker of inflammatory cells, into atherosclerotic plaques in mice//Basic Clin. Pharmacol. Toxicol. -2008. -Vol. 102, Is. Sup. S1. -P. 48-49.
Laitinen I., Saraste A., Weidl E. et al. Evaluation of alpha(v)beta(3) integrin-targeted positron emission tomography tracer F-18-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice//Circ. Cardiovasc. Imaging. -2009. -Vol. 2. -P. 331-338.
Li X., Samnick S., Lapa C. et al. 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors//EJNMMI Research. -2012. -Vol. 2. -P. 52.
Libby P. Inflammation in atherosclerosis//Nature. -2002. -Vol. 420. -P. 868-874.
Matter C.M., Wyss M.T., Meier P. et al. 18F-choline images murine atherosclerotic plaques ex vivo//Arterioscler. Thromb. Vasc. Biol. -2006. -Vol. 26. -P. 584-589.
Nahrendorf M., Keliher E., Panizzi P. et al. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis//J. Am. Coll. Cardiol. Cardiovasc. Imaging. -2009. -Vol. 2. -P. 1213-1222.
O’Rourke R.A., Brundage B.H., Froelicher V.F. et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease//J. Am. Coll. Cardiol. -2000. -Vol. 36. -P. 326-340.
Ogawa M., Ishino S., Mukai T. et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study//J. Nucl. Med. -2004. -Vol. 45. -P. 1245-1250.
Ohtsuki K., Hayase M., Akashi K. et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study//Circulation. -2001. -Vol. 104. -P. 203-208.
Opalinska M., Stompor T., Pach D. et al. Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients//Eur. J. Nucl. Med. Mol. Imaging. -2012. -Vol. 39. -P. 673-682.
Razavian M., Tavakoli S., Zhang J. et al. Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation//J. Nucl. Med. -2011. -Vol. 52. -P. 1795-1802.
Roger V.L., Go A.S., Lloyd-Jones D.M. et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association//Circulation. -2011. -Vol. 123. -e18-e209.
Rogers I.S., Nasir K., Figueroa A.L. et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina//J. Am. Coll. Cardiol. Img. -2010. -Vol. 3. -P. 388-397.
Rominger A., Saam T., Wolpers S. et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease//J. Nucl. Med. -2009. -Vol. 50. -P. 1611-1620.
Rudd J.H., Warburton E.A., Fryer T.D. et al. Imaging atherosclerotic plaque inflammation with -fluorodeoxyglucose positron emission tomography//Circulation. -2002. -Vol. 105. -P. 2708-2711.
Saam T., Rominger A., Wolpers S. et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study//Eur. J. Nucl. Med. Mol. Imaging. -2010. -Vol. 37. -P. 1203-1212.
Sarai M., Hartung D., Petrov A. et al. Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging//J. Am. Coll. Cardiol. -2007. -Vol. 50. -P. 23052312.
Sheikine Y., Akram K. FDG-PET imaging of Atherosclerosis: Do we know what we see?//Atherosclerosis. -2010. -Vol. 211. -P. 371-380.
Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress//Antioxid. Redox. Signal. -2009. -Vol. 11. -P. 2333-2339.
Tahara N., Kai H., Ishibashi M. et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography//J. Am. Coll. Cardiol. -2006. -Vol. 48. -P. 1825-1831.
Tawakol А., Migrino R.Q., Bashian G.G. et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients//J. Am. Coll. Cardiol. -2006. -Vol. 48. -P. 1818-1824.
Tekabe Y., Li Q., Luma J. et al. Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice//J. Nucl. Cardiol. -2010. -Vol. 17. -P. 1073-1081.
Teras M., Kokki T., Durand-Schaefer N. et al. Dual-gated cardiac PET-clinical feasibility study//Eur. J. Nucl. Med. Mol. Imaging. -2010. -Vol. 37. -P. 505-516.
Vallabhajosula S., Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine//J. Nucl. Med. -1997. -Vol. 38, № 11. -P. 1788-1796.
Vallabhajosula S., Machac J., Knesaurek K. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG)//J. Nucl. Med. -1996. -Vol. 37. -P. 38.
Wildgruber M., Swirski F.K., Zernecke A. Molecular imaging of inflammation in atherosclerosis//Theranostics. -2013. -Vol. 3. -P. 865-884.
Williams G., Kolodny G.M. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet//Am. J. Roentgenol. -2008. -Vol. 190. -W151-156.
Wykrzykowska J., Lehman S., Williams G. et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation//J. Nucl. Med. -2009. -Vol. 50. -P. 563-568.
Xia W., Hilgenbrink A.R., Matteson E.L. et al. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages//Blood. -2009. -Vol. 113. -P. 438-446.
Yun M., Jang S., Cucchiara A. et al. 18F FDG uptake in thelarge arteries: a correlation study with the atherogenic risk factors//Semin. Nucl. Med. -2002. -Vol. 32. -P. 70-76.
Zhao Y., Kuge Y., Zhao S. et al. Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/-mice//Eur. J. Nucl. Med. Mol. Imaging. -2007. -Vol. 34. -P. 1747-1755.

Еще

Статья научная